Fatal fibrosing alveolitis with certolizumab

Rheumatology

Volumn 51, Issue 5, 2012, Pages 953-955

  Millar, Auleen ^a   Mckew, Jennifer ^a   Taggart, Allister ^a  

^a MUSGRAVE PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CERTOLIZUMAB PEGOL; METHYLPREDNISOLONE; PREDNISOLONE;

AGED; ANAMNESIS; CLINICAL ARTICLE; CLINICAL FEATURE; FIBROSING ALVEOLITIS; HUMAN; LETTER; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; RESPIRATORY FAILURE; RHEUMATOID ARTHRITIS; THORAX RADIOGRAPHY; TREATMENT RESPONSE;

AGED; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FATAL OUTCOME; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; POLYETHYLENE GLYCOLS; PULMONARY FIBROSIS;

EID: 84860246124     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ker452     Document Type: Letter

References (9)

1. Ostor AJ, Chilvers ER, Somerville MF et al. Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis. J Rheumatol 2006;33:622-8.
2. Lindsay K, Melsom R, Jacob BK et al. Acute progression of interstitial lung disease: a complication of etanercept particularly in the presence of rheumatoid lung and methotrexate treatment. Rheumatology 2006;45: 1048-9.
3. Kramer N, Chuzhin Y, Kaufman LD et al. Methotrexate pneumonitis after initiation of infliximab therapy for rheumatoid arthritis. Arthritis Rheum 2002;47:670-1.
4. Quintos-Macasa AM, Quinet R. Enbrel-induced interstitial lung disease. South Med J 2006;99:783-4.
5. Huggett MT, Armstrong R. Adalimumab-associated pulmonary fibrosis. Rheumatology 2006;45:1312-3.
6. Schoe A, van der Laan-Baalbergen NE, Huizinga TW et al. Pulmonary fibrosis in a patient with rheumatoid arthritis treated with adalimumab. Arthritis Rheum 2006;55:157-9.
7. Hadjinicolaou AV, Nisar MK, Bhagat S et al. Non-infectious complications of newer biologic agents for rheumatic diseases-a systemic literature review. Rheumatology 2011;50:2297-305.
8. Braun J, Brandt J, Listing J et al. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet 2002;359:1187-93.
9. Dotan I, Yeshurun D, Hallak A et al. [Treatment of Crohn's disease with anti TNF alpha antibodies-the experience in the Tel Aviv Medical Center]. Harefuah 2001; 140:289-93.